Related Experiment Video
Updated: May 9, 2025
In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues
Published on: March 21, 2017
Non-hormonal Contraception: Current and Emerging Targets
Jessica A Marinaro1,2, Marc Goldstein3,4
1Department of Urology, Weill Cornell Medicine, New York, NY, USA.
Abstract:
There is a global need for effective, reversible contraception. While female hormonal options meet these criteria and are widely used, they are associated with side effects and may be contraindicated for women with certain pre-existing medical conditions. To meet the needs of women who cannot take or cannot tolerate these medications, several non-hormonal options are currently available, including copper intrauterine devices (IUDs), spermicides, and a new vaginal pH modulator (VPM). Several other options are currently in development, including vaginal rings, gels, and vaginally administered anti-sperm antibodies. For men, there are currently no contraceptive options available aside from condoms and vasectomy; however, several non-hormonal contraceptives targeting various aspects of sperm production and/or sperm function are currently under investigation. In this narrative review, we will discuss both the non-hormonal contraceptive methods currently available for women, as well as emerging non-hormonal medications, compounds, and devices for both genders.
More Related Videos
Related Concept Videos
01:22Birth Control Methods
01:22Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
01:26Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:30Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:31Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:22Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...